Scholars Central

Conference abstractPublished 18 Aug 2016

Therapeutic and synthetic approach towards indazole

Authors: Digambar D Gaikwad

Government College of Arts & Science, Maharashtra, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Among the various heterocyclic compounds, indazoles form a privileged class of core skeleton with their diverse spectrum of therapeutic potential. The easy generation of complex molecular diversity is broadly applicable, cost effective, practical and sustainable. Synthetic methods in a straight forward fashion along with the importance of these motifs in biological and pharmaceutical applications received significant attention from researchers engaged in drug design. Fused 1H-indazole and 2H-indazole are well recognized for anti-hypertensive, anticancer properties antibacterial, anti-depressant and anti-inflammatory activities. New YC-1 indazole derivatives were synthesized and evaluated with HIF-1 transcriptional activity, in vivo. Furthermore, for the mechanistic study of the YC-1 derivatives, shows the anti-proliferative activity against human cancer cells and 1,3,5-trisustituted indazole derivative as an extremely potent antioxidant. The 7-nitro indazoles derivative was tested for the treatment of alcohol dependence, anti-mutagenesis and anti-oxidant properties. Similarly piperidine derivative of indazole has been patented as a non-narcotic, analgesic and antipsychotic drug. The indazole ring system is also present in many other compounds such as herbicides, dyes and sweeteners. Granisetron, serotonin 5-HT3 receptor antagonist used is to treat and prevent nausea and vomiting induced by cancer chemotherapy. Pan-Kinase inhibitor anthrapyrazolone is rationally used for designing of indazoles based potent of cell-active Mps1 kinase inhibitors. The new paradigm is to develop eco-friendly and green procedures for the construction of bioactive indazole compounds in order to help medicinal chemists in designing and synthesizing novel and potent compounds for the treatment of different disorders.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Medicinal Chemistry.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Digambar D Gaikwad”